Clinical trials
Autoimmune Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 26 |
| 2025 | 29 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 48 |
| Unknown status | 23 |
| Completed | 17 |
| Not yet recruiting | 13 |
| Withdrawn | 8 |
| Active, not recruiting | 6 |
| Terminated | 3 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 10 |
| Zhejiang University | 7 |
| The Children's Hospital of Zhejiang University School of Medicine | 6 |
| Beijing Boren Hospital | 5 |
| Anhui Provincial Hospital | 3 |
| Changhai Hospital | 3 |
| Essen Biotech | 3 |
| Nanjing Legend Biotech Co. | 3 |
| Novartis Pharmaceuticals | 3 |
| RemeGen Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 120 |
| Lupus Erythematosus, Systemic | 32 |
| Scleroderma, Systemic | 17 |
| Immune System Diseases | 16 |
| Myositis | 11 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 10 |
| Recurrence | 10 |
| Sjogren's Syndrome | 10 |
| Connective Tissue Diseases | 8 |
| Arthritis, Rheumatoid | 7 |
Trials
Showing 51 to 75 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.